Przedstawiamy wybór publikacji naukowych związanych z immunoterapią IOZK. Możesz użyć filtrów, aby dokonać wyboru według typów nowotworów i metod lub wprowadzić wyszukiwane hasła.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002007-02-20 / Eur J Surg Oncol 2007 Dec;33(10):1191-8https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2007-02-20 / Eur J Surg Oncol 2007 Dec;33(10):1191-82007-02-20 00:00:002019-02-15 08:38:08A study of dendritic and endothelial cell interactions in colon cancer in a cell line and small mammal model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002007-02-09 / Cancer Res 2007 Feb;67(4):1842-52https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2007-02-09 / Cancer Res 2007 Feb;67(4):1842-522007-02-09 00:00:002023-03-07 13:12:37Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002007-02-07 / Cancer Immunol Immunother 2007 Sep;56(9):1485-99https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2007-02-07 / Cancer Immunol Immunother 2007 Sep;56(9):1485-992007-02-07 00:00:002023-03-07 13:13:36Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002007-02-01 / Int. J. Cancer 2007 Feb;120(3):585-93https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2007-02-01 / Int. J. Cancer 2007 Feb;120(3):585-932007-02-01 00:00:002019-02-15 08:38:13Successful cancer vaccine therapy for carcinoembryonic antigen (CEA)-expressing colon cancer using genetically modified dendritic cells that express CEA and T helper-type 1 cytokines in CEA transgenic mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002007-02-01 / Leuk. Lymphoma 2007 Feb;48(2):302-10https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2007-02-01 / Leuk. Lymphoma 2007 Feb;48(2):302-102007-02-01 00:00:002019-02-15 08:48:42Generation of functional dendritic cells (DC) in adult acute lymphoblastic leukemia: rationale for a DC-based vaccination program for patients in complete hematological remission
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002007-01-19 / Cancer Gene Ther. 2007 Apr;14(4):409-20https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2007-01-19 / Cancer Gene Ther. 2007 Apr;14(4):409-202007-01-19 00:00:002019-02-15 08:48:20Enhanced T-cell immunity induced by dendritic cells with phagocytosis of heat shock protein 70 gene-transfected tumor cells in early phase of apoptosis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002007-01-03 / Vaccine 2007 Mar;25(14):2610-9https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2007-01-03 / Vaccine 2007 Mar;25(14):2610-92007-01-03 00:00:002007-01-03 00:00:00Generation and functional assessment of antigen-specific T cells stimulated by fusions of dendritic cells and allogeneic breast cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002007-01-01 / Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2007 Jan;23(1):60-2https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2007-01-01 / Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2007 Jan;23(1):60-22007-01-01 00:00:002007-01-01 00:00:00[Induction of specific CTL by DC from axillary lymph node of patients with breast cancer]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002007-01-01 / Tumori 2007 Jan-Feb;93(1):26-30https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2007-01-01 / Tumori 2007 Jan-Feb;93(1):26-302007-01-01 00:00:002007-01-01 00:00:00Results of a pilot trial of immunotherapy with dendritic cells pulsed with autologous tumor lysates in patients with advanced cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002007-01-01 / Vitam Horm 2007;76:463-91https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2007-01-01 / Vitam Horm 2007;76:463-912007-01-01 00:00:002021-06-30 13:46:31Vitamin E analogues and immune response in cancer treatment
A study of dendritic and endothelial cell interactions in colon cancer in a cell line and small mammal model
Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion
Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers
[Malignant peritoneal mesothelioma. Our experienced with triple combined therapy: cytoreduction, intraperitoneal perioperative chemotherapy and hyperthermia]
Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro
A novel dendritic cell-based cancer vaccine produces promising results in a syngenic CC-36 murine colon adenocarcinoma model
Successful cancer vaccine therapy for carcinoembryonic antigen (CEA)-expressing colon cancer using genetically modified dendritic cells that express CEA and T helper-type 1 cytokines in CEA transgenic mice
A dendritic cell-based vaccine for treating HIV infection: background and preliminary results
Dendritic cell vaccine strategies for renal cell carcinoma
Generation of functional dendritic cells (DC) in adult acute lymphoblastic leukemia: rationale for a DC-based vaccination program for patients in complete hematological remission
Enhanced T-cell immunity induced by dendritic cells with phagocytosis of heat shock protein 70 gene-transfected tumor cells in early phase of apoptosis
Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics
Systemic efficacy with oncolytic virus therapeutics: clinical proof-of-concept and future directions
p53-independent endoplasmic reticulum stress-mediated cytotoxicity of a Newcastle disease virus strain in tumor cell lines
Induction of dendritic cell-mediated immune responses against canine malignant melanoma cells
Generation and functional assessment of antigen-specific T cells stimulated by fusions of dendritic cells and allogeneic breast cancer cells
[Induction of specific CTL by DC from axillary lymph node of patients with breast cancer]
Results of a pilot trial of immunotherapy with dendritic cells pulsed with autologous tumor lysates in patients with advanced cancer
[Immunotherapy and malignant mesothelioma: clinical perspectives]
Vitamin E analogues and immune response in cancer treatment